Emergency Management-EM has published Supply Of Medical Consumables For Veterinary On Annual Rate Contract Basis- Activated Charcoal Powder 50 Gms, Adrenaline 1Ml I.V., Bolus Nitrofurazone+Urea ( Interauterine ) , Bolus. Sulphonamide + Trimethoprin, Boric Powder ( 450Gm ) , Cefotaxim Inj.. Submission Date for this Tender is 14-10-2021. Cleaning and Disinfecting Solutions Tenders in Gujarat. Bidders can get complete Tender details and download the document.
Sl. No. | Item Title | Details |
1 | Activated Charcoal Powder 50 Gms | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
2 | Adrenaline 1ml I.V. | Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection |
3 | Bolus Nitrofurazone+Urea (Interauterine) | Each Bolus must contain minimum of Nitrofurazone 60mg+Nitrofurazone 6gm |
4 | Bolus. Sulphonamide + Trimethoprin | Each Bolus must contain Sulphadiazine 1000 mg+Trimethoprim 200 mg. |
5 | Boric Powder (450gm) | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
6 | Cefotaxim Inj. (250 mg) | Each vial contain 250 mg cefotaxim sodium IP |
7 | Cephalexin Tablet (600mg) | Each tablate must contain Cephalexin 600mg |
8 | Ciprofloxacillin Eye/Ear Drops | Ciprofloxacin eye drop IP - 10 ml |
9 | Diminazine Aceturate (90ml) Multi-Dose | Each ml must contain minimum of Diminazine Aceturate/Diaceturate 70mg+Phenazone 375mg |
10 | Disinfectant Tablet Form | Must contain Sodium Hypochloride |
11 | Fly repellent cream (100 gm) | Must contain Gamabenzene hexachloride 0.10 % and Proflavine hemisulphate 0.10% with cetrimide cream 0.45% |
12 | Frusemide (Redema) Inj. (10 ml) | Frusemide 50mg i.p. |
13 | H2O2 Hydrogen peroxide (100ml) | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
14 | Herbal Spray 100ML | Antiseptic wound healing and skin spray 100 ml |
15 | Inj. Amoxycillin + Cloxacilin (4.5gm) | Each vial contain amoxycillin 2.25gm and cloxacyllin 2.25gm |
16 | Inj. Atropine HCL (100ml) | Atropine Sulphate I.P Inj. 10 mg/ml Inj |
17 | Inj. Butorphanol (1ml) | 1 ml of solution for injections contains 2 mg of butorphanol sodium tartrate |
18 | Inj. Calcium + Vit. D3 + Vit. B12 (100 Ml) | Each ml contains : Calcium Levulinate :76.4 mg + Vit D 3(Chole Calciferol)5000 IU + Vit B 12 (Cynocobalamine)50 mcg |
19 | Inj. Calcium Borogluconate (450ml) | Each 450 ml must contain minimum of calcium gluconate 20.75% w/v + Proportion of Boric acid (4.25%w/v)+ Chlorocresol 0.1 % w/v(as preservative) + Water for injection q.s. |
20 | Inj. Chlorpheneramine Maleate (100ml) | Each ml must contain minimum of Chlorpheneramine Maleate 10mg |
21 | Inj. Dexamethasone (5ml) | Each ml must contain minimum Dexamethasone Sodium Phosphate 4.4 mg equivalent to dexamethasone phosphate 4mg |
22 | Inj. Dextrose 5% (500ml) | Each 100ml must contain minimum of Dextrose 5gm |
23 | Inj. Enrofloxacin (100ml) | Each ml must contain minimum of Enrofloxacin 100mg |
24 | Inj. Ethamsylate 20 ml | Each ml must contain minimum of Ethamsylate 125mg |
25 | Inj. Flunixin Meglumine (50ml) | Each 1 ml must contain 83 mg flunixin meglumine equivalent to flunixin 50 mg |
26 | Inj. Gentamycin (100ml) | Each ml must contain minimum of Gentamicin sulphate 40 mg equivalents to 40 mg of gentamicin base in stable stabilizer |
27 | Inj. Ivermectin (100ml) | Ivermectin 1% Inj. |
28 | Inj. Lignocaine (30ml) (2%) | Each must contain minimum of Lignocaine Hydrochloride 20 mg |
29 | Inj. Meloxicam 100ml | Each ml must contain 5 mg meloxicam |
30 | Inj. Metronidazole (100ml) | Metronidazole intravenous infusion I.P. 500mg/100ml |
31 | Inj. Normal Saline (500ml) | Each 100ml must contain minimum of sodium chloride 0.9 gm water for injection q.s. |
32 | Inj. Oxytetracycline (100ml) | Each ml must contain minimum of oxytetracycline Hydrocloride equivalent to anhydrous oxytetracycline 50mg |
33 | Inj. Pantoprazole 40mg | Pantoprazole for injection B.P. 40mg |
34 | Inj. Phosphorus 100ml | Each ml must containminimum of Sodium salt of 4-dimethylamino 2-methyl phenyl phosphoric acid 0.2 gm + Phenylethenol (as preservative) 0.6 % w/v |
35 | Inj. Prednisolone (10ml) | Each 1 ml must contain 10 mg prednisolone acetate |
36 | Inj. Ranitidine (30ml) | Each 1 ml must contain 25 mg ranitidine HCL |
37 | Inj. Ringer Lactate (500ml) | Sodium Lactate 0.32% + Sodium Chloride 0.60% + Potassium Chloride 0.40% + Calcium Chloride 0.27% |
38 | Inj. Sodium Bicarbonate (10ml) | injection sodium bicarbonate 7.5 % |
39 | Inj. Streptomycin+Procaine penicillin (2.5gm) | Each vial must contain streptomycin sulphate IP equivalent to 2.5 gm of base, procaine penicillin G IP 15,00,000 unit , penicillin G sodium IP 5,00,000. |
40 | Inj. Sulfadimidine (100 ml) | Sulphadimidine injection 33.3 % - 100 ml |
41 | Inj. Thiophyline | Each 1 ml must contain Etophylin- 84.7 mg and theophyline 25.3 mg |
42 | Inj. Tolfenamic Acid (100ml) | Each ml must contain minimum of Tolfenamic Acid 40 mg with suitable preservative |
43 | Inj. Triamcenaloneacetonide (5ml) | Each ml must contains Triamcinolone acetonide : 6 mg |
44 | Inj. Valethamate Bromide (30ML) | Each ml must contain minimum of Valethamate Bromide 10 mg |
45 | Inj. Vit B Complex with Liver Extract(100ml Vial) | Each ml must contain minimum of Thiamine Hydrochloride 10mg + Riboflavin phosphate sodium 3mg + Niacinamide 100mg + vitaminB12 10mcg+ Liver extract crude 0.66ml + 0.5 phenol 0.5% |
46 | Inj. Vit B1, B6 & B12(100ml) | Each ml must contain B1 (50mg), B2 (50mg) and B12 (500mcg) |
47 | Inj. Vitamin A, D3 & E | Each ml must contain minimum of Vitamin A 250000 I.U.+ Vitamin D3 25000 I.U. + Vitamin E 100mg/I.U. |
48 | Inj. Xylazinen (30ml) | Each ml must contain minimum of Xylazine Hcl 23.32mg (Equivalent to 20 mg xyline) |
49 | Intra mammary infusion Streptopenicillin + Sulphamerazine | Each syringe must contain minimum of Procaine penicillin g 100000 units+Strptomycin sulphate+100mg+Sulphamerazine 500mg+Hydrocortisone 20mh |
50 | Isopropyle Rubbing Alcohol (Surgicle Spirit) 400ML | 70% isopropyl rubbing alcohol 400ml |
51 | KMnO4 Crystals (20 gm) | Potassium permanganate crystels - 20 gm |
52 | Lignocain 2% Gel 30 GM | Lignocaine hydrochloride Gel 2 % USP - 30 gm |
53 | Liquid Paraffin (400 Ml) | Liquid paraffin IP - 400 ml |
54 | Liquid Simethicone (100 Ml) | Each 100ml must contain minimum of Simethicone Emulsion 1% w/v + Anethi oil & Soya Lecithin |
55 | meloxicam oral drop 10ml | Meloxicam oral suspension BP |
56 | Meloxicam Tab. (15 mg) | Meloxicam tablet 15 mg |
57 | Metaclopromide 10ml | Each 2 ml contains metoclopramide hydrochloride BP equivalent to 10 mg of anhydrous metoclopramide hydrochloride - 10 ml |
58 | Nylon (Monofilfment) non-absorbent no 2 roll single | 2 meter Roll |
59 | Ondansetron Injection 2ml | Each ampoule with 2 ml contains 4 mg ondansetron |
60 | Oxytetracycline L A (Long acting) 100 ml | Each ml must contain minimum of oxytetracycline Dihydrate 200mg in a suitable vehicle system |
61 | Povidine Iodine Ointment 5% 250 Gms. | Available iodine 0.5% w/w,water soluble ointment base q.s. |
62 | Povidone Iodine I.P 5% Liquid (500 Ml) | Each 500ml must must contain minimum of Povidone iodine 5% w/v with 0.5% available active ingredient |
63 | Sodium Bicarbonate Powder 200 Gms | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
64 | Tab Ivermectin (10 mg) | Each tablet must contain 10 mg ivermectin |
65 | Tab Metronidazole 400 Mg | Metronidazole Tablet 400 mg |
66 | Tetracycline Hydrochloride powder (100gm) | Each gm must contain minimum of Tetracyline Hydrochoride 50 mg |
67 | Tincture Benzoin (450 Ml) | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
68 | Tincture Iodine (450ml) | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
69 | Turpentine Oil (400 ML) | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |
70 | ZincOxide (450 Gm) | (IP/BP//USP/NF/BPC/NFI/As permissible under II shedule of Drugs & Cosmetics Act, 1940/Cosmetic rules, 1945) |